Table 3.

The effect size for each of the patient-reported outcomes from hospitalisation to 7, 14, 21, 28, 56 and 84 days

Patient-reported outcomes	Days 1–7		Days 1–14		Days 1–21		Days 1–28		Days 1–56		Days 1–84
	n	Effect size	n	Effect size	n	Effect size	n	Effect size	n	Effect size	n	Effect size
EXACT total score	32	−1.14	31	−1.40	32	−1.09	33	−1.25	30	−1.29	27	−1.18
Breathlessness domain score	33	−0.91	32	−1.08	32	−0.75	33	−0.87	30	−0.89	27	−0.74
Cough and sputum domain score	33	−0.70	32	−1.21	32	−1.03	33	−0.97	30	−1.10	27	−1.14
Chest symptoms domain score	33	−1.10	32	−1.50	32	−1.12	33	−1.29	30	−1.44	27	−1.26
CAT score	33	−1.04	32	−1.36	32	−1.24	33	−1.31	30	−1.28	27	−1.17
SGRQ total score	31	−0.24	30	−0.59	30	−0.47	30	−0.51	27	−0.59	25	−0.52
SGRQ symptoms	31	0.18	30	−0.14	30	−0.05	30	−0.23	28	−0.47	26	−0.38
SGRQ activity	31	−0.32	30	−0.56	30	−0.37	30	−0.37	27	−0.45	25	−0.38
SGRQ impact	31	−0.24	30	−0.59	30	−0.56	31	−0.66	28	−0.61	26	−0.59
Hyland Scale score	31	0.77	30	0.96	28	0.86	30	0.78	26	0.91	25	0.81
D-12 total score	28	−0.54	29	−0.90	28	−0.76	29	−0.76	27	−0.82	24	−0.75
D-12 physical score	29	−0.57	29	−1.04	28	−0.86	29	−0.85	27	−0.99	24	−0.86
D-12 affective score	29	−0.50	30	−0.71	29	−0.60	30	−0.62	28	−0.58	26	−0.61

Data are presented as mean±SD.

CAT, COPD Assessment Test; COPD, chronic obstructive pulmonary disease; D-12, Dyspnoea-12; EXACT, Exacerbations of Chronic Pulmonary Disease Tool; SGRQ, St George’s Respiratory Questionnaire.